跳至主要内容
临床试验/NCT00200668
NCT00200668终止不适用

Comparison Between FDG-PET and MRI for the Assessment of Response to Intensive Chemotherapy in Multiple Myeloma Patients.

Nantes University Hospital2 个研究点 分布在 1 个国家开始时间: 2005年3月1日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
终止
试验地点
2

研究概览

简要总结

Comparison between FDG-PET and MRI for the assessment of response to intensive chemotherapy in multiple myeloma patients.

详细描述

First whole body FDG-PET scan and MRI before the start of the treatment. Second whole body FDG-PET scan and MRI after the end of the treatment. On a basis of patient, comparison between PET and MRI will be done tumoral site by site. Sensitivity, Specificity will be estimated for both techniques. In case of discrepancy, another imaging method or biopsy (if easy to perform) will be serve as standard of reference. Kappa coefficients and Mc Nemar test will be performed to compare the two methods. FDG = fluorodeoxyglucose FLUCIS® (Schering-CisBio® international)

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients from 18 to 65 years old.
  • De novo histologically proven multiple myeloma.

排除标准

  • No history of another cancer or of HIV
  • No history of renal failure

研究者

申办方类型
Other

研究点 (2)

Loading locations...

相似试验